Sep 2026· Movement Disorders· 0 citations· 10 references
Medicine
TL;DR
Dopaminergic depletion is associated with a targeted SMN reorganization, potentially maintaining network information flow despite progressive hub loss, and whether this reorganization represents compensation or a consequence of progressive pathology requires further longitudinal assessment.
Abstract
INTRODUCTION
Network attack tolerance (NAT) measures the brain's ability to sustain information flow despite the loss of critical brain regions. In Parkinson's disease (PD), NAT has been linked to cognitive and motor function. However, it remains unclear how dopaminergic degeneration shapes NAT, and whether it relates to motor symptom progression.
Objective
To examine dopamine deficiency-related changes in NAT across the early PD disease continuum and its association with longitudinal motor outcomes.
Methods
We used cross-sectional resting-state functional magnetic resonance imaging of 28 healthy controls, 60 prodromal, and 94 clinical PD patients to create graph-theoretical networks. NAT was assessed at the global and subnetwork levels by calculating the global efficiency upon iterative node removal at different network densities. Using linear mixed-effects models, we assessed how putaminal dopamine transporter (DaT) binding or disease status affected NAT, controlling for network density, age, sex, and education. Baseline somatomotor (SMN) NAT was examined as a predictor of motor symptom progression in 145 patients.
Results
Lower putaminal DaT signal was associated with higher SMN NAT across groups. PD patients exhibited elevated SMN NAT relative to controls. Neither global nor other subnetworks showed effects. While the effect of baseline SMN NAT on motor progression was not significant, an exploratory analysis (Johnson-Neyman) suggested that higher SMN NAT may associate with slower motor decline across most of the observed NAT range.
While nigrostriatal dopaminergic cell loss is the pathological hallmark of Parkinson's disease, it is well-known that dopamine deficiency cannot fully explain the clinical severity or disease progression. Emerging data suggest that resilience, i.e. the brain's capacity to maintain function despite pathology, plays a ke...
M. C. Ruppert-Junck, T. van Eimeren, Kathrin Giehl et al.· Brain : a journal of neurolo...· 0 citations
BACKGROUND
The thalamus is a core node of the basal ganglia-thalamocortical circuit implicated in Parkinson's disease (PD) and depression. This study examined associations among thalamic volume ratio (TVR), nigrostriatal dopaminergic degeneration, and depressive symptoms in PD.
METHODS
We included 170 PD patients wit...
Bradykinesia is a cardinal motor feature of Parkinson’s disease and is characterised by a reduced ability to generate movements with normal speed and force. Although nigrostriatal dopamine loss is regarded as the primary cause, direct human evidence linking dopaminergic degeneration to striatal dysfunction and impaired...
B. L. C. Thomsen, V. Labanauskas, N. Raaf et al.· bioRxiv· 0 citations
Parkinson's disease (PD) and multiple system atrophy (MSA) are alpha-synuclein-related neurodegenerative disorders with overlapping motor and non-motor symptoms but distinct pathology, clinical management, and prognosis. Early differential diagnosis, particularly between PD and the parkinsonian subtype of MSA (MSA-P),...
Dai-Chao Chen, Hua-Da Tang, Yan-Fei Pan et al.· NeuroImage: Clinical· 0 citations
Alzheimer’s disease (AD) is marked by progressive network disconnection that begins decades before symptoms emerge, yet detecting early functional disruptions remains a key challenge. Transcranial magnetic stimulation combined with electroencephalography (TMS–EEG) provides a direct, non-invasive probe of cortical...
G. Bertazzoli, E. Canu, C. Bagattini et al.· Alzheimer's Research & T...· 0 citations
ABSTRACT Background Dynamic analysis of resting‐state fMRI (rs‐fMRI) offers a novel approach to differentiate Parkinson's disease (PD) from progressive supranuclear palsy (PSP) by capturing temporal features of brain network activity, which may shed light on the mechanisms underlying non‐motor symptoms. Objectives To c...
Chen-Fei Ye, Jia-Hui Shi, Ji-Liang Fang et al.· CNS Neuroscience & Therapeut...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.